AIM ImmunoTech CEO and President Equels Thomas K purchased 22,000 shares at $0.22 each on September 15, 2026, in an open-market transaction classified with code P. His resulting holding was 91,822 shares, while the purchase represented about 24.0% of that holding, giving investors a stated view of the transaction’s size.

Key Highlights

  • Equels Thomas K’s resulting AIM ImmunoTech holding stood at 91,822 shares.
  • Transaction code P identifies the purchase as an open-market transaction.
  • The transaction represented about 24.0% of Equels Thomas K’s resulting share holding.

AIM ImmunoTech Inc. (AMEX: AIM) CEO & President Equels Thomas K bought 22,000 shares at $0.22 per share. The purchase took place on 15 September 2026, placing the total transaction value on a per-share basis at the reported price.

Open-Market Purchase Recorded Transaction

code P classifies the deal as an open-market purchase. Following the transaction, Equels Thomas K owned 91,822 AIM ImmunoTech shares. The reported purchase represented about 24.0% of his resulting share holding.